ストックスクリーナーアプリを入手
4.01
5.65%
-0.24
前日終値:
$4.25
開ける：
$4.08
24時間の取引高:
12,583
Relative Volume:
0.00
時価総額：
$43.37M
収益：
-
当期純損益:
$-16.89M
株価収益率:
-0.192
EPS:
-20.8847
ネットキャッシュフロー:
$-16.44M
1週間 パフォーマンス:
+1,079%
1か月 パフォーマンス:
+740.67%
6か月 パフォーマンス:
+158.71%
1年 パフォーマンス:
-4.98%
1日の値動き範囲:
$4.00
$4.135
1週間の範囲:
$0.279
$4.36
52週間の値動き範囲:
$0.25
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
4.10 | 3.61M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
373.03 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
191.17 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.46 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.09 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.82 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc (GCTK) 最新ニュース
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia - marketscreener.com
Form 8K GlucoTrack Inc For: 19 August By Investing.com - Investing.com Nigeria
Glucotrack shareholders approve director elections, reverse split, and warrant inducement - Investing.com
Glucotrack Shareholders Approve Up to 1-for-30 Reverse Stock Split - Minichart
Glucotrack (NASDAQ: GCTK) investors back reverse split, warrant deal - Stock Titan
GlucoTrack Stock Short Interest Rises to 33.15% - Quiver Quantitative
GlucoTrack, Inc. (GCTK) Latest Stock News & Headlines - Yahoo Finance
Glucotrack Regains Nasdaq Equity Compliance as Strategic Transformation Advances - Yahoo Finance
Glucotrack regains Nasdaq compliance on equity requirement By Investing.com - Investing.com South Africa
Glucotrack regains Nasdaq compliance on equity requirement - Investing.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Business Wire
Glucotrack Company Profile & Introduction - Moomoo
Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan
GlucoTrack, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks
GlucoTrack Inc (GCTK) Stock News Today - tradingkey.com
GlucoTrack Secures New Financing to Support Growth - The Globe and Mail
Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io
E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times
Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart
Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView
GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz
Glucotrack Announces $5.5 Million Financing - marketscreener.com
Lōkahi Therapeutics Ai2 Futures Lab Changes How Biopharma Builds a Pipeline - 富途牛牛
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline - marketscreener.com
GlucoTrack (GCTK) Shares Crash 40% to $0.47 as Critical Support Level ApproachesGap Up Stocks - vinanet.vn
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - webull.com
GlucoTrack surges as traders revisit Lōkahi merger and new financing package | GCTK Stock News - Quiver Quantitative
GlucoTrack, Inc. (NASDAQ:GCTK) surges 95% after LT-100 news, market eyes dilution impact - TechStock²
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Glucotrack (NASDAQ: GCTK) revises $900,000 debt-for-stock deal - Stock Titan
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration - Yahoo Finance
GlucoTrack Restructures Debt Through Equity-Linked Note Exchange - theglobeandmail.com
GlucoTrack Creates $900,000 Partitioned Note, Enables Exchanges Into Stock at Market-Based Price - TradingView
Glucotrack (NASDAQ: GCTK) creates $900,000 exchangeable note for stock - Stock Titan
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Income Statement - TradingKey
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
GCTK|GlucoTrack Inc|Price:0.297|Chg%:+0.006 - TradingKey
GCTK|GlucoTrack Inc|Price:0.294|Chg%:+0.003 - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GCTK|GlucoTrack Inc|Price:0.291|Chg%:-0.021 - TradingKey
Glucotrack Inc (GCTK) 財務データ
収益
当期純利益
現金流量
EPS
0.35%
1.33%
大文字化:
|
ボリューム (24 時間):